Aesica Zwickau Marks 20th Anniversary with Continued Growth and Expansion of its Encapsulation Services Business
Aesica celebrates the 20th anniversary of its site located at Zwickau in Germany. The facility possesses multiple solid oral dosage form technologies and service capabilities and has been integral in fast establishing Aesica as a leading provider of encapsulation services.
The immediate and controlled release technology enables Aesica to work with powders, pellets and tablets into capsules. The company has invested in technology and now has a range of encapsulation machines which are fully equipped with 100% weight control units. The modern machinery allows Aesica to utilise various capsule formats in addition to the capability to fill different materials into the capsules concerned.
Aesica Zwickau has emerged as a multi-purpose, advanced bulk production site for solid dose forms. It has the capability to conduct small scale trials and is equipped with a pilot scale laboratory that facilitates product and process transfer, formulation development and improvement of production processes. As well as encapsulation and tableting, Aesica Zwickau manufactures solid dose medicinal products through a variety of other technologies. This includes strong expertise in pelletizing, both layering of pellets and extrusion technology. In addition, granulation capabilities, which range from high steer mixers, fluid bed granulation and drying and vacuum granulation technology are on offer. A broad range of bin blenders, tablet-presses and coaters enables the company to carry out blending steps, as well as compression and film coating of tablets.
The site, which was first constructed as a manufacturing facility back in 1994, and later acquired by Aesica in 2011, now employs 200 skilled personnel. Aesica Zwickau is equipped with analytical capabilities ranging from analytical tests for raw materials and bulk products including microbiological testing, analytical methods development and validation. Moreover, product and process development is offered including manufacturing process transfer, formulation checks, improvement and validation of processes, carried out in the company’s own pilot-scale laboratory, and clinical trials supply. Recent technological developments have included the installation of new driam tablet coater technology and on-going investment in 2014 in new compaction machinery that fully complement existing capabilities.
Aesica Zwickau is fully compliant with a multitude of regulations including the Local German Health Authority in the EU, FDA, ANVISA, the Gulf Country Council and the Korean FDA. Currently, products manufactured at Zwickau are marketed in the EU, the US, the Middle East, Asia, Japan and South America including Brazil.
Tomasz Zytkiewicz, Site Director at Aesica Zwickau commented: “We are very pleased with the continued success of our site at Zwickau and what has been achieved to date during its first twenty years of operation. We consider this testimony to the quality of the site’s technology, facilities and personnel. In particular, our strong expertise in encapsulation and pelletizing of solid dose medicinal products has marked the site out as an important contributor to the overall success of the Aesica Group”.
Related News
-
News Patients vs Pharma – who will the Inflation Reduction Act affect the most?
The Inflation Reduction Act brought in by the Biden administration in 2022 aims to give better and more equitable access to healthcare in the USA. However, pharma companies are now concerned about the other potential costs of such legislation. -
News CPHI Podcast Series: What does the changing US Pharma market mean for industry and patients alike?
In this week's episode of the CPHI Podcast Series Lucy Chard, Digital Editor for CPHI Online is joined by James Manser to discuss the political and market changes in the US pharma field. -
News CPHI Barcelona Annual Report illuminates industry trends for 2024
The CPHI Annual Survey comes into it’s 7th year to report on the predicted trends for 2024. Over 250 pharma executives were asked 35 questions, with their answers informing the industry landscape for the next year, spanning all major pharma marke... -
News Which 10 drugs are open to price negotiation with Medicare in the USA?
The Centres for Medicare & Medicaid Services, under the Biden administration in the USA, has released a list of the 10 drugs that will be open to price negotiations as part of the new legislation under the Inflation Reduction Act (IRA). -
News EU Medical Devices Regulation causes unintended disappearances of medical devices for children, doctors state
Doctor groups and associations have appealed to the EU to correct the EU Medical Devices Regulation law that may cause unintended shortages of essential drug and medical devices for children and rare disease patients. -
News 10 Major Drug Approvals So Far in 2023
Last year, 37 novel drugs were approved by the FDA, this was a high number for such a category, and covered many fields including oncology, demonstrating how promising further research is, and how it is only continuing to build. To date, there are alre... -
News Detecting Alzheimer's disease with a simple lateral flow test
A novel rapid diagnostic test for early-stage Alzheimer's disease has been developed using a biomarker binder from Aptamer Group along with technology from Neuro-Bio, the neurodegenerative disease experts. -
News CPHI Podcast Series: outsourcing and manufacturing trends
Listen to the CPHI Podcast Series this June to hear Gil Roth of the PBOA speak with Digital Editor Lucy Chard about the biggest trends and topics to watch in pharma outsourcing and manufacturing at the minute.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance